Simcere Pharmaceutical Group in Going-Private Transaction

Cleary Gottlieb is representing the buyer consortium, including Mr. Jinsheng Ren, Chairman of the Board of Directors, and his affiliate New Good Management Limited, Mr. Hongquan Liu, Chief Executive Officer, Assure Ahead Investments Limited, an affiliate of Hony Capital II, L.P., Right Lane Limited, a wholly owned subsidiary of Legend Holdings Limited, King View Development International Limited, an affiliate of Trustbridge Partners II, L.P. and Fosun Industrial Co., Ltd, in the going-private transaction of Simcere Pharmaceutical Group. The merger agreement was executed and announced on August 28. The merger will be financed by a bank loan from China Merchants Bank, New York Branch, and the rollover of the existing equity in the company held by the buyer consortium. The closing is expected to take place around the end of 2013, subject to the approval of shareholders and other customary closing conditions.

Simcere Pharmaceutical Group is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China. Its ADSs are listed on the NYSE.